In comparison, a vaccine being developed in partnership from Oxford University and drug maker AstraZenca is offering the cheapest price point per dose at $4, when it will be sold to the British government. AstraZenca has been heavily supported by the government, which has allowed the giant to stick to non-profit principles.
fredag 21. august 2020
Chinese Vaccine Giant Price COVID Dose 36 Times Higher than Oxford University
Chinese-state owned pharmaceutical giant, Sinopharm, has priced their experimental COVID-19 vaccine at 1,000 yuan ($145 USD), a number 36 times higher than the vaccine candidate from Oxford University. Sinopharm Chairman Liu Jingzhen estimated the value of the company's two-dose vaccine on Tuesday, according the Guangming Daily. However, it was unclear if he was referring to the retail or wholesale cost of the drug, which is estimated to be available this December.
In comparison, a vaccine being developed in partnership from Oxford University and drug maker AstraZenca is offering the cheapest price point per dose at $4, when it will be sold to the British government. AstraZenca has been heavily supported by the government, which has allowed the giant to stick to non-profit principles.
In comparison, a vaccine being developed in partnership from Oxford University and drug maker AstraZenca is offering the cheapest price point per dose at $4, when it will be sold to the British government. AstraZenca has been heavily supported by the government, which has allowed the giant to stick to non-profit principles.
